Abid Hamid Selected Research

boswellic acid

10/2014	Design, synthesis and biological evaluation of β-boswellic acid based HDAC inhibitors as inducers of cancer cell death.
6/2013	NF-κB down-regulation and PARP cleavage by novel 3-α-butyryloxy-β-boswellic acid results in cancer cell specific apoptosis and in vivo tumor regression.
7/2012	PARP cleavage and perturbance in mitochondrial membrane potential by 3-α-propionyloxy-β-boswellic acid results in cancer cell death and tumor regression in murine models.
1/2012	Acyl derivatives of boswellic acids as inhibitors of NF-κB and STATs.
1/2011	A propionyloxy derivative of 11-keto-β-boswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase I & II inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abid Hamid Research Topics

Disease

37	Neoplasms (Cancer) 11/2022 - 12/2008
11	Alcoholism (Alcohol Abuse) 04/2012 - 12/2005
9	Body Weight (Weight, Body) 04/2012 - 09/2007
5	Leukemia 01/2019 - 01/2011
4	Pre-Eclampsia (Preeclampsia) 01/2022 - 10/2014
4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 09/2013
3	Triple Negative Breast Neoplasms 11/2022 - 08/2019
3	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2012
3	Carcinoma (Carcinomatosis) 01/2019 - 06/2013
3	Neuroblastoma 04/2018 - 02/2014
3	Colonic Neoplasms (Colon Cancer) 08/2016 - 06/2013
3	Lung Neoplasms (Lung Cancer) 01/2015 - 06/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 04/2018
2	Breast Neoplasms (Breast Cancer) 08/2019 - 01/2018
2	Hydatidiform Mole (Molar Pregnancy) 02/2017 - 10/2014
2	Colorectal Neoplasms (Colorectal Cancer) 12/2016 - 10/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016 - 06/2013
2	Avitaminosis (Vitamin Deficiency) 04/2012 - 04/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Digital Dermatitis 01/2017
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2016
1	Inflammation (Inflammations) 12/2015
1	Carcinogenesis 01/2015
1	Pancreatitis 01/2013
1	Virus Diseases (Viral Diseases) 01/2013
1	Parasitic Diseases (Parasitic Disease) 08/2011

Drug/Important Bio-Agent (IBA)

15	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 12/2005
9	Ethanol (Ethyl Alcohol)IBA 04/2012 - 09/2007
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2007
5	boswellic acidIBA 10/2014 - 01/2011
5	SolutionsIBA 03/2012 - 09/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2019 - 12/2015
3	Caspase 3 (Caspase-3)IBA 08/2019 - 10/2014
3	ChromatinIBA 01/2019 - 10/2014
3	lissamine rhodamine B (sulforhodamine B)IBA 09/2013 - 06/2013
3	AcidsIBA 06/2013 - 01/2011
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2018 - 01/2016
2	Histones (Histone)IBA 02/2017 - 10/2012
2	DNA (Deoxyribonucleic Acid)IBA 02/2017 - 10/2014
2	EnzymesIBA 12/2016 - 04/2012
2	Betulinic AcidIBA 05/2016 - 05/2013
2	TriazolesIBA 05/2016 - 09/2014
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2015 - 01/2013
2	Histone Deacetylase InhibitorsIBA 10/2014 - 10/2012
2	ludartinIBA 02/2014 - 09/2013
2	LipidsIBA 03/2012 - 08/2011
2	Reduced Folate Carrier ProteinIBA 03/2009 - 12/2007
1	ChemokinesIBA 11/2022
1	Adapalene (Differin)FDA LinkGeneric 01/2022
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2022
1	Dimethoate (Rogor)IBA 10/2020
1	CollagenIBA 01/2020
1	Fibronectins (Fibronectin)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	LactonesIBA 01/2019
1	osthol (osthole)IBA 01/2019
1	3- rhamnopyranosyl(1- 4)- glucopyranosyl- 12- diacetoxy- 20- hydroxywitha- 5,24- dienolideIBA 04/2018
1	Glutamic Acid (Glutamate)FDA Link 04/2018
1	7-hydroxycoumarin (umbelliferone)IBA 01/2018
1	Cytostatic AgentsIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017
1	Therapeutic UsesIBA 01/2017
1	QuinazolinonesIBA 12/2016
1	Antineoplastic Agents (Antineoplastics)IBA 08/2016
1	alborixinIBA 08/2016
1	ethyl acetateIBA 08/2016
1	Cytotoxins (Cytolysins)IBA 08/2016
1	Cyclin D1IBA 05/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2016
1	skyrinIBA 03/2016
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	Colchicine FDA LinkGeneric 05/2015
1	QuinazolinesIBA 04/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	N 30IBA 10/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2014
1	Volatile Oils (Essential Oils)IBA 05/2014
1	Iridoid GlucosidesIBA 01/2014
1	boschnalosideIBA 01/2014
1	plantarenalosideIBA 01/2014
1	IridoidsIBA 01/2014
1	LectinsIBA 12/2013
1	Protein Isoforms (Isoforms)IBA 12/2013
1	Ursolic AcidIBA 08/2013
1	AntioxidantsIBA 06/2013
1	TrypsinIBA 01/2013
1	Peptide Hydrolases (Proteases)FDA Link 01/2013
1	Chymotrypsin FDA Link 01/2013
1	Pancreatic Elastase (Elastase)IBA 01/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2012
1	TransferasesIBA 10/2012
1	Pentacyclic TriterpenesIBA 07/2012
1	Folic Acid TransportersIBA 03/2012
1	bakuchiolIBA 03/2012
1	CholesterolIBA 08/2011

Therapy/Procedure

8	Therapeutics 11/2022 - 07/2012
4	Drug Therapy (Chemotherapy) 01/2022 - 10/2012
1	Radiotherapy 12/2021